[Thoughts and practice on the treatment of severe and critical new coronavirus pneumonia].
Zhonghua Jie He He Hu Xi Za Zhi
; 43(5): 396-400, 2020 May 12.
Article
in Chinese
| MEDLINE | ID: covidwho-9384
ABSTRACT
Severe and critical coronavirus pneumonia 2019 (COVID-19) often occurs in elder patients with multiple comorbidities, and severe hypoxemia events constitute a key factor for the deterioration of some cases. The critical type of COVID-19 could progress into acute respiratory distress syndrome and multi-organ dysfunction, which are the major causes of death. Early non-invasive ventilation (NIV) treatment of possible pathophysiological abnormalities is helpful to improve prognosis. Close monitoring of oxygenation, reducing patients' oxygen consumption, active psychological intervention, and rapid handling of severe hypoxemia events are the key factors for successful NIV treatment. In addition, active adjuvant therapies such as correcting coagulation dysfunction, providing proper nutritional support, accurate volume control, and safe individualized blood glucose monitoring are of great significance.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pneumonia
/
Pneumonia, Viral
/
Coronavirus Infections
/
Pandemics
Type of study:
Observational study
/
Prognostic study
Topics:
Long Covid
Limits:
Aged
/
Humans
Language:
Chinese
Journal:
Zhonghua Jie He He Hu Xi Za Zhi
Year:
2020
Document Type:
Article
Affiliation country:
Cma.j.cn112147-20200312-00320
Similar
MEDLINE
...
LILACS
LIS